These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Delaware
|
27-3046338
|
|||
|
(State of incorporation)
|
(IRS Employer ID Number)
|
|
Large accelerated filer
|
o
|
Accelerated filer
|
o
|
|
Non-accelerated filer
|
x
|
Smaller reporting company
|
o
|
|
Page
|
|
|
PART I
|
|
|
Item 1. Financial Statements
|
1 |
|
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
|
15 |
|
Item 3. Quantitative and Qualitative Disclosures About Market Risk
|
17 |
|
Item 4. Controls and Procedures
|
18 |
|
PART II
|
|
|
Item 1. Legal Proceedings
|
18 |
|
Item 1A. Risk Factors
|
18 |
|
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
|
18 |
|
Item 3. Defaults Upon Senior Securities
|
19 |
|
Item 4. Mine Safety Disclosures
|
19 |
|
Item 5. Other Information
|
19 |
|
Item 6. Exhibits
|
19 |
|
Item1.
|
Financial Statements.
|
|
|
Page(s) |
|
Statements of Assets and Liabilities –
|
|
|
As of March 31, 2014 (unaudited) and December 31, 2013
|
2 |
|
Statements of Operations (unaudited) –
|
|
|
Three months ended March 31, 2014 and 2013
|
3 |
|
Statement of Changes in Net Assets (unaudited) –
|
|
|
Three months ended March 31, 2014 and 2013
|
4 |
|
Statements of Cash Flows (unaudited) –
|
|
|
Three months ended March 31, 2014 and 2013
|
5 |
|
Schedule of Investments as of March 31, 2014 (unaudited)
|
6 |
|
Schedule of Investments as of December 31, 2013
|
7 |
|
Notes to Financial Statements (unaudited)
|
8 - 14 |
|
March 31,
2014
|
December 31,
2013
|
|||||||
|
(unaudited)
|
||||||||
|
ASSETS
|
||||||||
|
Investments at fair value
|
||||||||
|
Non-controlled/Non-affiliated investments (cost $481,023 and $131,021)
|
$ | 1,012,311 | $ | 196,164 | ||||
|
Cash and cash equivalents
|
1,916,913 | $ | 2,010,620 | |||||
|
Interest receivable
|
3,600 | 600 | ||||||
|
Other assets
|
342 | - | ||||||
|
Total Assets
|
$ | 2,933,166 | $ | 2,207,384 | ||||
|
LIABILITIES
|
||||||||
|
Accounts payable and accrued expenses
|
$ | 12,011 | $ | 2,050 | ||||
|
Notes payable
|
- | 15,000 | ||||||
|
Interest payable
|
- | 1,667 | ||||||
|
Total Liabilities
|
12,011 | 18,717 | ||||||
|
Redeemable Series A, Convertible Preferred stock, $0.0001 par value, 5,000,000 shares
authorized, 1,000,000 shares designated; 4,000 and none issued and outstanding ($100 per share redemption value)
|
400,000 | 400,000 | ||||||
|
NET ASSETS
|
||||||||
|
Common stock, $0.0001 par value, 100,000,000 shares authorized;
48,382,440 and 40,606,200 shares issued and outstanding |
4,839 | 4,061 | ||||||
|
Additional paid-in capital
|
3,215,531 | 2,919,449 | ||||||
|
Accumulated net investment loss
|
(102,503 | ) | (71,986 | ) | ||||
|
Accumulated undistributed net realized gain on investments
|
39,754 | 39,754 | ||||||
|
Unrealized appreciation on investments
|
531,288 | 65,143 | ||||||
|
Accumulated deficit during development stage
|
(1,167,754 | ) | (1,167,754 | ) | ||||
|
Total Net Assets
|
2,521,155 | 1,788,667 | ||||||
|
Total Liabilities and Net Assets
|
$ | 2,933,166 | $ | 2,207,384 | ||||
|
Net Asset Value per common share
|
$ | 0.05 | $ | 0.04 | ||||
|
Three Months Ended March 31,
|
||||||||
|
2014
|
2013
|
|||||||
|
INVESTMENT INCOME
|
||||||||
|
Interest income
|
||||||||
|
Non-controlled/Non-affiliated investments
|
$ | 3,003 | $ | - | ||||
|
EXPENSES
|
||||||||
|
Professional fees
|
27,228 | |||||||
|
Filing fees
|
1,632 | |||||||
|
General and administrative expenses
|
4,660 | 22,882 | ||||||
|
Total expenses
|
33,520 | 22,882 | ||||||
|
Net investment loss
|
(30,517 | ) | - | |||||
|
Net change in unrealized appreciation on investments
|
||||||||
|
Non-controlled/Non-affiliated investments
|
466,145 | - | ||||||
|
NET INCREASE IN NET ASSETS RESULTING FROM OPERATIONS
|
$ | 435,628 | $ | - | ||||
|
Net loss
|
- | $ | (22,882 | ) | ||||
|
Net loss per common share - basic and diluted (1)
|
- | $ | (0.00 | ) | ||||
|
Weighted average number of common shares outstanding during the period - basic and diluted (1)
|
- | 30,634,533 | ||||||
|
Common Stock,
$0.0001 Par Value
|
Additional
Paid In
|
Accumulated
Net
Investment
|
Accumulated
Undistributed Net
Realized
Gain On
|
Unrealized Appreciation
On
|
Accumulated
Deficit
Development
|
Total
Net
Assets
|
||||||||||||||||||||||||||
|
Shares
|
Amount
|
Capital
|
Loss
|
Investments
|
Investments
|
Stage
|
(Deficit)
|
|||||||||||||||||||||||||
|
Balance - December 31, 2012
|
30,631,200 | $ | 3,063 | $ | 1,123,497 | $ | - | $ | - | $ | - | $ | (1,167,754 | ) | $ | (41,194 | ) | |||||||||||||||
|
Common stock issued ($0.20/share)
|
100,000 | 10 | 19,990 | - | - | - | - | 20,000 | ||||||||||||||||||||||||
|
Net loss
|
- | - | - | - | - | - | (22,882 | ) | (22,882 | ) | ||||||||||||||||||||||
|
Balance - March 31, 2013
|
30,731,200 | $ | 3,073 | $ | 1,143,487 | $ | - | $ | - | $ | - | $ | (1,190,636 | ) | $ | (44,076 | ) | |||||||||||||||
|
Balance - December 31, 2013
|
40,606,200 | $ | 4,061 | $ | 2,919,449 | $ | (71,986 | ) | $ | 39,754 | $ | 65,143 | $ | (1,167,754 | ) | $ | 1,788,667 | |||||||||||||||
|
Common stock issued ($0.20/share)
|
1,650,000 | 165 | 329,835 | - | - | - | - | 330,000 | ||||||||||||||||||||||||
|
Shares issued for services
|
6,126,240 | 613 | 1,224,635 | - | - | - | - | 1,225,248 | ||||||||||||||||||||||||
|
Offering costs
|
- | - | (1,258,388 | ) | - | - | - | - | (1,258,388 | ) | ||||||||||||||||||||||
|
Increase (decrease) in net assets resulting from operations
|
- | - | - | (30,517 | ) | - | 466,145 | - | 435,628 | |||||||||||||||||||||||
|
Balance - March 31, 2014
|
48,382,440 | $ | 4,839 | $ | 3,215,531 | $ | (102,503 | ) | $ | 39,754 | $ | 531,288 | $ | (1,167,754 | ) | $ | 2,521,155 | |||||||||||||||
|
Three Months Ended March 31,
|
||||||||
|
2014
|
2013
|
|||||||
|
CASH FLOWS FROM OPERATING ACTIVITIES:
|
||||||||
|
Net increase in net assets resulting from operations
|
$ | 435,628 | $ | - | ||||
|
Net loss
|
- | (22,882 | ) | |||||
|
Adjustments to reconcile net increase in net assets/net loss to net cash used in operating activities:
|
||||||||
|
Purchases of investments
|
(350,002 | ) | - | |||||
|
Net
change in unrealized appreciation on investments
|
(466,145 | ) | - | |||||
|
Increase in interest receivable
|
(3,000 | ) | - | |||||
|
Increase in other assets
|
(342 | ) | - | |||||
|
Increase in accounts payable and accrued expenses and interest payable
|
8,294 | 12,699 | ||||||
|
Net Cash Used In Operating Activities
|
(375,567 | ) | (10,183 | ) | ||||
|
CASH FLOWS FROM FINANCING ACTIVITIES:
|
||||||||
|
Repayment of notes payable
|
(15,000 | ) | - | |||||
|
Proceeds from issuance of common stock
|
330,000 | 20,000 | ||||||
|
Offering costs
|
(33,140 | ) | - | |||||
|
Net Cash Provided By Financing Activities
|
281,860 | 20,000 | ||||||
|
Net Increase (Decrease) in cash and cash equivalents
|
(93,707 | ) | 9,817 | |||||
|
Cash and cash equivalents - Beginning of period
|
2,010,620 | 279 | ||||||
|
Cash and cash equivalents - End of period
|
$ | 1,916,913 | $ | 10,096 | ||||
|
Supplemental Disclosure of Cash Flow Information:
|
||||||||
|
Interest paid
|
$ | 1,726 | $ | - | ||||
|
Taxes Paid
|
$ | 775 | $ | - | ||||
|
Noncash Financing Activities
|
||||||||
|
Issuance of common stock for services
|
$ | 1,225,248 | $ | - | ||||
|
Offering costs
|
$ | (1,225,248 | ) | $ | - | |||
|
POINT CAPITAL, INC.
|
|||||||||||||
|
SCHEDULE OF INVESTMENTS
|
|||||||||||||
|
March 31, 2014
|
|||||||||||||
|
(Unaudited)
|
|
Fair
|
% of
|
|||||||||||||||||||
|
Company
|
Industry
|
Type of Investment
|
Principal/Shares
|
Cost
|
Value
|
Net Assets
|
||||||||||||||
|
Non-controlled/Non-affiliated investments
|
||||||||||||||||||||
|
Intercloud Systems, Inc. (1)
|
Commercial Services
|
12% Convertible Debenture (Due 06/2015)
|
$ | 100,000 | $ | 100,000 | $ | 106,792 | 4.24 | % | ||||||||||
|
Common Stock
|
315 | - | 2,140 | 0.08 | % | |||||||||||||||
|
CombiMatrix Corp.(2)
|
Biotechnology
|
Warrants
|
35,835 | 31,021 | 79,569 | 3.16 | % | |||||||||||||
|
Be Active Holdings, Inc. (1)(2)
|
Commercial Services
|
Common Stock
|
6,062,801 | 100,000 | 336,486 | 13.35 | % | |||||||||||||
|
Ruthigen, Inc. (2)
|
Biotechnology
|
Common Stock
|
20,690 | 149,795 | 141,520 | 5.61 | % | |||||||||||||
|
Series A Warrants
|
20,690 | 207 | 62,025 | 2.46 | % | |||||||||||||||
|
Arista Power, Inc. (1)
|
Electrical Components & Equipment
|
Series A Convertible Preferred Stock
|
100,000 | 46,505 | 87,000 | 3.45 | % | |||||||||||||
|
Warrants
|
750,000 | 53,495 | 196,779 | 7.80 | % | |||||||||||||||
|
Total Non-controlled/Non-affiliated investments
|
$ | 481,023 | $ | 1,012,311 | 40.15 | % | ||||||||||||||
|
Reconciliation to Net Assets:
|
||||||||||||||||||||
|
Investments at fair value
|
$ | 1,012,311 | 40.15 | % | ||||||||||||||||
|
Cash and cash equivalents
|
1,916,913 | 76.03 | % | |||||||||||||||||
|
Liabilities in excess of other assets
|
(408,069 | ) | (16.18 | )% | ||||||||||||||||
|
Net Assets
|
$ | 2,521,155 | 100.00 | % | ||||||||||||||||
|
POINT CAPITAL, INC.
|
|
SCHEDULE OF INVESTMENTS
|
|
As of December 31, 2013
|
|
Fair
|
% of
|
|||||||||||||||||||
|
Company
|
Industry
|
Type of Investment
|
Principal/Shares
|
Cost
|
Value
|
Net Assets
|
||||||||||||||
|
Non-controlled/Non-affiliated investments
|
||||||||||||||||||||
|
Intercloud Systems, Inc. (1)
|
Commercial Services
|
12% Convertible Debenture (Due 06/2015)
|
$ | 100,000 | $ | 100,000 | $ | 144,340 | 8.07 | % | ||||||||||
|
Common Stock
|
315 | - | 2,891 | 0.16 | % | |||||||||||||||
|
CombiMatrix Corp.(1)(2)
|
Biotechnology
|
Warrants
|
35,835 | 31,021 | 48,933 | 2.74 | % | |||||||||||||
|
Total Non-controlled/Non-affiliated investments
|
$ | 131,021 | $ | 196,164 | 10.97 | % | ||||||||||||||
|
Reconciliation to Net Assets:
|
||||||||||||||||||||
|
Investments at fair value
|
$ | 196,164 | 10.97 | % | ||||||||||||||||
|
Cash and cash equivalents
|
2,010,620 | 112.41 | % | |||||||||||||||||
|
Liabilities in excess of other assets
|
(418,117 | ) | (23.38 | )% | ||||||||||||||||
|
Net Assets
|
$ | 1,788,667 | 100.00 | % | ||||||||||||||||
|
2.
|
Summary of Significant Accounting Policies
|
|
Level 1
|
Level 2
|
Level 3
|
Total
|
|||||||||||||
|
Common Stock
|
$ | 141,520 | $ | - | $ | 338,626 | $ | 480,146 | ||||||||
|
Convertible Preferred
|
- | - | 87,000 | 87,000 | ||||||||||||
|
Convertible Debentures
|
- | - | 106,792 | 106,792 | ||||||||||||
|
Warrants
|
- | 141,594 | 196,779 | 338,373 | ||||||||||||
|
Total Investments
|
$ | 141,520 | $ | 141,594 | $ | 729,197 | $ | 1,012,311 | ||||||||
|
Level 1
|
Level 2
|
Level 3
|
Total
|
|||||||||||||
|
Common Stock
|
$ | - | $ | - | $ | 2,891 | $ | 2,891 | ||||||||
|
Convertible Debentures
|
- | - | 144,340 | 144,340 | ||||||||||||
|
Warrants
|
- | 48,933 | - | 48,933 | ||||||||||||
|
Total Investments
|
$ | - | $ | 48,933 | $ | 147,231 | $ | 196,164 | ||||||||
|
Balance at January 1, 2014
|
$ | 147,231 | ||
|
Purchase of investments
|
350,002 | |||
|
Net change in unrealized appreciation on investments
|
231,964 | |||
|
Balance at March 31, 2014
|
$ | 729,197 | ||
|
Net change in unrealized appreciation in earnings relating to assets still held
|
$ | 231,964 |
|
Fair Value at
March 31,
2014
|
Valuation Technique
|
Unobservable inputs
|
Input
|
||||||||
|
Investments, at fair value
|
|||||||||||
|
Common stock
|
$ | 2,140 |
Comparable market value
|
Restriction discount
|
20 | % | |||||
|
Common stock
|
$ | 336,486 |
Comparable market value
|
Restriction discount
|
50 | % | |||||
|
Convertible preferred
|
$ | 87,000 |
Comparable market value
|
Restriction discount
|
40 | % | |||||
|
Convertible debentures
|
$ | 106,792 |
Comparable market value
|
Restriction discount
|
20 | % | |||||
|
Warrants
|
$ | 196,779 |
Comparable market value
|
Restriction discount
|
40 | % | |||||
|
Fair Value at
December 31,
2013
|
Valuation Technique
|
Unobservable inputs
|
Input
|
||||||||
|
Investments, at fair value
|
|||||||||||
|
Common stock
|
$ | 2,891 |
Comparable market value
|
Restriction discount
|
50 | % | |||||
|
Convertible debentures
|
$ | 144,340 |
Comparable market value
|
Restriction discount
|
50 | % | |||||
|
3.
|
Notes Payable
|
|
4.
|
Redeemable Series A, Convertible Preferred Stock
|
|
5.
|
Financial Highlights (Unaudited)
|
|
Net asset value per common share data:
|
||||
|
Net asset value, beginning of period
|
$ | 0.04 | ||
|
Net investment loss
|
(0.00 | ) | ||
|
Net change in unrealized appreciation on investments
|
0.01 | |||
|
Net increase in net assets resulting from operations
|
0.01 | |||
|
Capital stock transactions:
|
||||
|
Issuance of common stock (2)
|
0.00 | |||
|
Offering costs from issuance of common stock
|
(0.00 | ) | ||
|
Net increase in net assets from capital stock transactions
|
0.00 | |||
|
Net asset value, end of period
|
$ | 0.05 | ||
|
Ratios and supplemental data:
|
||||
|
Per share market price, end of period (3)
|
$ | - | ||
|
Total return (4)
|
23.49 | % | ||
|
Common shares outstanding, end of period
|
48,382,440 | |||
|
Weighted average common shares outstanding during period
|
42,096,283 | |||
|
Net assets, end of year
|
$ | 2,521,155 | ||
|
Ratio of operating expenses to average net assets (annualized)
|
(6.33 | )% | ||
|
Ratio of net investment loss to average net assets (annualized)
|
(5.76 | )% | ||
|
1.
|
Prior to October 4, 2013, the Company was not an investment company. Accordingly, financial highlights are presented for the three months ended March 31, 2014 only.
|
|
2.
|
Issuance of common stock for the three months ended March 31, 2014 based on the average increase in net asset value attributable to each share issued in the Company's offerings during such period.
|
|
3.
|
The shares of the Company's common stock were listed in the OTC Market beginning January 4, 2012. There was no market price for the shares as of March 31, 2014.
|
|
4.
|
Total return based on change in net asset value during the period, adjusted for the impact of capital stock transactions and related offering costs.
Since there was no market price, total return based on stock price has not been presented for the three months ended March 31, 2014. Total return is not annualized.
|
|
Item2.
|
Management’s Discussion and Analysis of Financial Condition and Results of Operations
|
|
●
|
Strong management teams with meaningful equity ownership.
We will seek experienced management teams with an established track record of success in place or available. We will typically require the portfolio companies to have proper incentives to align management’s goals with ours. Generally, we will seek companies in which the management teams have significant equity interests.
|
|
●
|
Secure market positions that present attractive growth opportunities.
We will seek companies that we believe possess advantages in scale, scope, customer loyalty, product pricing, or product quality versus their competitors, minimizing sales risk and generating margins that can be readily forecast.
|
|
●
|
Industries with favorable trends.
We will seek industries with favorable industry trends and companies performing well within their industries and poised to benefit from a catalyst.
|
|
●
|
Investing in private companies
. We do not expect to invest in start-up companies or companies with speculative business plans. We may also consider companies that are underperforming compared to their potential due to structural impediments with opportunities to restructure and refocus strategy and resources.
|
|
●
|
Investing primarily in senior loans
. Under normal market conditions, approximately 65% of the value of our future net assets (including the amount of any borrowings for investment purposes) is expected be invested in senior loans. Senior loans typically pay interest at rates which are determined periodically on the basis of a floating base lending rate, primarily LIBOR, plus a premium. Senior loans typically are rated below investment grade, and may be considered “high risk” compared to debt instruments that are rated above investment grade. Senior loans, however, are generally less risky than subordinated debt.
|
|
●
|
Diversification
. We will seek to diversify our portfolio among companies engaged in a variety of industries, thereby potentially reducing the risk of a downturn in any one industry having a disproportionate impact on the value of our portfolio. We cannot assure you that we will be successful in this regard.
|
|
●
|
Structure financing terms to limit down side risk.
Originating our own lending opportunities through our network will permit us to structure loans to enhance the element of capital preservation for our stockholders.
|
|
●
|
Private equity sponsorship
. Often we will seek to participate in transactions sponsored by what we believe to be high-quality private equity firms. Point Capital’s senior management team believes that a private equity sponsor’s willingness to invest significant sums of equity capital into a company provides an additional level of due diligence investigation and is an implicit endorsement of the quality of the investment. Further, by co-investing with quality private equity firms which commit significant sums of equity capital with junior priority to our future debt investments, we may benefit from having due diligence on our investments performed by both parties.
|
|
●
|
Viable exit strategy
. We intend to focus our investment activity primarily in companies whose business models and growth prospects offer attractive exit possibilities, including repayment of our investments, with the potential for capital gain on any equity interest we hold through an initial public offering of common stock, a merger, a sale or other recapitalization. See “Investment Objectives and Strategy.”
|
|
Item 3.
|
Quantitative and Qualitative Disclosures about Market Risk.
|
|
Item 4.
|
Controls and Procedures.
|
|
Item 1.
|
Legal Proceedings.
|
|
Item 1A.
|
Risk Factors
|
|
Item 2.
|
Unregistered Sales of Equity Securities and Use of Proceeds.
|
|
Exhibit No.
|
Description
|
|
|
31.1
|
Rule 13a-14(a)/15d14(a) Certifications of Richard A Brand, the Principal Executive Officer*
|
|
|
31.2
|
Rule 13a-14(a)/15d14(a) Certifications of Vadim Mats, the Principal Financial Officer*
|
|
|
32.1
|
Section 1350 Certifications of Richard A. Brand, the Principal Executive Officer*
|
|
|
32.2
|
Section 1350 Certifications of Vadim Mats, the Principal Financial Officer*
|
|
POINT CAPITAL, INC.
|
|||
|
By:
|
/s/ Richard A. Brand
|
||
|
Name: Richard A. Brand
|
|||
|
Title: Chairman, Chief Executive Officer and Director (Principal Executive Officer)
|
|||
|
Dated: May 2, 2014
|
|||
|
By:
|
/s/ Vadim Mats
|
||
|
Name: Vadim Mats
|
|||
|
Title: Chief Financial Officer (Principal Financial and Accounting Officer)
|
|||
| Dated: May 2, 2014 | |||
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|